Hoffman: FTC won't accept pipeline divestitures in certain mergers
The acting director of the Federal Trade Commission's bureau of competition has said that the commission will no longer accept the divestiture of pipeline products to remedy anticompetitive mergers in the inhalant and injectable drug industries.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10